Neuronetics (STIM) Cash from Investing Activities Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -4,224.26% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 95.53% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 3.20% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -18.20% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -208.79% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -187.82% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -397.90% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -514.25% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -211.17% |
| 10 | Neuronetics | 3.26 Mn | -6.42 Mn | 16.15 Mn | 21.46% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.46% |
| Dec 31, 2025 | 90.91% |
| Sep 30, 2025 | -914.29% |
| Jun 30, 2025 | -111.76% |
| Mar 31, 2025 | -422.06% |
| Dec 31, 2024 | -322.02% |
| Sep 30, 2024 | -78.79% |
| Jun 30, 2024 | 81.46% |
| Mar 31, 2024 | 137.16% |
| Dec 31, 2023 | -11.93% |
| Sep 30, 2023 | -99.29% |
| Jun 30, 2023 | 33.54% |
| Mar 31, 2023 | 82.96% |
| Dec 31, 2022 | 37.20% |
| Sep 30, 2022 | 216.95% |
| Jun 30, 2022 | -123.09% |
| Mar 31, 2022 | -59.11% |
| Dec 31, 2021 | -596.52% |
| Sep 30, 2021 | -5,953.44% |
| Jun 30, 2021 | -98.62% |
| Mar 31, 2021 | -153.76% |
| Dec 31, 2020 | 67.97% |
| Sep 30, 2020 | -133.93% |
| Jun 30, 2020 | -75.81% |
| Mar 31, 2020 | 2.92% |
| Dec 31, 2019 | 0.55% |
| Sep 30, 2019 | 59.12% |
| Jun 30, 2019 | 42.59% |
| Mar 31, 2019 | 7.74% |
| Dec 31, 2018 | -31.27% |
| Sep 30, 2018 | 17.96% |